Ablynx: Goldman Sachs Biotech Symposium (Ablynx) - Sep 13, 2014 - Anticipated initiation of P2b trial for RA in Q1 2015; Anticipated initiation of P2b trial for SLE in Q1 2015; Anticipated P1 data for subcutaneous formulation for RA in Q4 2014
Anticipated new P2b trial • Anticipated P1 data • Immunology • Rheumatoid Arthritis
|